Insider · CIK 0001738422

Alva Emily Peterson

Reports to the SEC for 2 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001738422

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+34.8K sh	—	—	34,819
2025-05-05	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+40.3K sh	—	—	211,029
2025-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−40.3K sh	—	—	0
2025-03-05	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−80K sh	$8.90	−$712K	170,771
2024-06-29	ALKSAlkermes plc.M Exercise/Conversion	Director	MExercise/Conversion	+6,104 sh	—	—	28,767
2024-06-29	ALKSAlkermes plc.F Tax Payment	Director	FTax Payment	−1,465 sh	$24.10	−$35.3K	27,302
2024-06-29	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	Director	MExercise/Conversion	−6,104 sh	—	—	0
2024-06-09	ALKSAlkermes plc.M Exercise/Conversion	Director	MExercise/Conversion	+3,871 sh	—	—	23,593
2024-06-09	ALKSAlkermes plc.F Tax Payment	Director	FTax Payment	−930 sh	$23.91	−$22.2K	22,663
2024-06-09	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	Director	MExercise/Conversion	−3,871 sh	—	—	0
2024-05-31	ALKSAlkermes plc. · Restricted Stock Unit AwardA Award	Director	AAward	+8,013 sh	—	—	8,013
2024-05-31	ALKSAlkermes plc. · Non Qualified Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,492
2024-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+76.5K sh	—	—	250,771
2024-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−76.5K sh	—	—	0
2024-05-02	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+40.3K sh	—	—	40,258
2023-11-17	ALKSAlkermes plc. · Non Qualified Stock Option (Right to Buy)J Other	Director	JOther	+22 sh	$24.22	+$532.84	1,137
2023-11-17	ALKSAlkermes plc. · Non Qualified Stock Option (Right to Buy)J Other	Director	JOther	+455 sh	$24.22	+$11K	23,214
2023-11-17	ALKSAlkermes plc. · Restricted Stock Unit AwardJ Other	Director	JOther	+75 sh	—	—	3,871
2023-11-17	ALKSAlkermes plc. · Non Qualified Stock Option (Right to Buy)J Other	Director	JOther	+313 sh	$24.24	+$7,587.12	15,990
2023-11-17	ALKSAlkermes plc. · Non Qualified Stock Option (Right to Buy)J Other	Director	JOther	+231 sh	$30.86	+$7,128.66	11,785
2023-11-17	ALKSAlkermes plc. · Non Qualified Stock Option (Right to Buy)J Other	Director	JOther	+254 sh	$30.72	+$7,802.88	12,986
2023-11-17	ALKSAlkermes plc. · Restricted Stock Unit AwardJ Other	Director	JOther	+119 sh	—	—	6,104
2023-07-07	ALKSAlkermes plc.M Exercise/Conversion	Director	MExercise/Conversion	+5,957 sh	—	—	21,152
2023-07-07	ALKSAlkermes plc.F Tax Payment	Director	FTax Payment	−1,430 sh	$29.88	−$42.7K	19,722
2023-07-07	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	Director	MExercise/Conversion	−5,957 sh	—	—	0
2023-06-29	ALKSAlkermes plc. · Non Qualified Stock Option (Right to Buy)A Award	Director	AAward	+12.7K sh	—	—	12,732
2023-06-29	ALKSAlkermes plc. · Restricted Stock Unit AwardA Award	Director	AAward	+5,985 sh	—	—	5,985
2023-06-09	ALKSAlkermes plc.M Exercise/Conversion	Director	MExercise/Conversion	+3,795 sh	—	—	16,106
2023-06-09	ALKSAlkermes plc.F Tax Payment	Director	FTax Payment	−911 sh	$31.13	−$28.4K	15,195
2023-06-09	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	Director	MExercise/Conversion	−3,795 sh	—	—	3,796
2023-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+80.1K sh	—	—	174,318
2023-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−80.1K sh	—	—	0
2023-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+76.5K sh	—	—	76,453
2022-07-07	ALKSAlkermes plc. · Restricted Stock Unit AwardA Award	Director	AAward	+5,957 sh	—	—	5,957
2022-07-07	ALKSAlkermes plc. · Non Qualified Stock Option (Right to Buy)A Award	Director	AAward	+11.6K sh	—	—	11,554
2022-06-14	ALKSAlkermes plc.M Exercise/Conversion	Director	MExercise/Conversion	+7,585 sh	—	—	13,216
2022-06-14	ALKSAlkermes plc.F Tax Payment	Director	FTax Payment	−905 sh	$27.19	−$24.6K	12,311
2022-06-14	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	Director	MExercise/Conversion	−7,585 sh	—	—	0
2022-06-09	ALKSAlkermes plc.M Exercise/Conversion	Director	MExercise/Conversion	+532 sh	—	—	2,182.165
2022-06-09	ALKSAlkermes plc.F Tax Payment	Director	FTax Payment	−43 sh	$28.13	−$1,209.59	2,139.165
2022-06-09	ALKSAlkermes plc.M Exercise/Conversion	Director	MExercise/Conversion	+3,796 sh	—	—	5,935.165
2022-06-09	ALKSAlkermes plc.F Tax Payment	Director	FTax Payment	−304 sh	$28.13	−$8,551.52	5,631.165
2022-06-09	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	Director	MExercise/Conversion	−532 sh	—	—	0
2022-06-09	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	Director	MExercise/Conversion	−3,796 sh	—	—	7,591
2022-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+80.1K sh	—	—	80,128
2022-05-08	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+35.4K sh	—	—	94,190
2022-05-08	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−35.4K sh	—	—	0
2021-08-23	ALKSAlkermes plc.P Purchase	Director	PPurchase	+1,650.165 sh	$30.22	+$49.9K	1,650.165
2021-06-14	ALKSAlkermes plc. · Non Qualified Stock Option (Right to Buy)A Award	Director	AAward	+15.7K sh	—	—	15,677
2021-06-14	ALKSAlkermes plc. · Restricted Stock Unit AwardA Award	Director	AAward	+7,585 sh	—	—	7,585

Recent filings

Accepted (ET)
May 84
Alva Emily Peterson0001628280-25-023987
SEC(opens sec.gov)
Mar 74
Alva Emily Peterson0001628280-25-011300
SEC(opens sec.gov)
Jul 14
Alva Emily Peterson0001127602-24-019581
SEC(opens sec.gov)
Jun 104
Alva Emily Peterson0001127602-24-018322
SEC(opens sec.gov)
Jun 44
Alva Emily Peterson0001127602-24-017710
SEC(opens sec.gov)
May 144
Alva Emily Peterson0001628280-24-023262
SEC(opens sec.gov)

Companies

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD

BRIDGEWATER, NJ, 08807